Zeki Data Introduces Company Diagnostics for Deep-Tech Risk Assessment

Zeki Data has launched a new tool called Company Diagnostics, aimed at revealing hidden risks within deep-tech companies. Announced in a press release, this tool leverages Zeki's global Talent IQ dataset to provide insights into organizational health that go beyond traditional financial metrics.

Company Diagnostics combines workforce, financial, and competitive signals to offer a predictive view of a company's execution strength and scaling capability. It is designed to help investors and strategists make informed decisions by surfacing overlooked signals such as talent alignment, technical depth, and execution readiness.

The tool tracks 1,500 companies across 30+ countries, covering 3 million professionals in over 4,500 domains and 100+ deep-tech verticals. It offers decision-ready delivery options, including rapid PDF snapshots or full data feeds, to support both continuous monitoring and high-stakes decision-making. This service is particularly beneficial for venture capital, private equity, public market investors, and M&A teams looking to enhance diligence and benchmark scaling momentum.